celecoxib has been researched along with formaldehyde in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bräutigam, L; Geisslinger, G; Niederberger, E; Tegeder, I; Vetter, G | 1 |
| Alonso-López, R; Asomoza-Espinosa, R; Ferreira, SH; Gomes-Lopes, LD; Granados-Soto, V; Rufino, MO | 1 |
| Nozaki-Taguchi, N; Yamamoto, T | 1 |
| Alonso-López, R; Asomoza-Espinosa, R; Castañeda-Hernández, G; Granados-Soto, V; Ortiz, MI; Torres-López, JE | 1 |
| Salam, OM | 1 |
| Chichorro, JG; Lorenzetti, BB; Zampronio, AR | 1 |
| Avila, MN; da Motta, PG; Duarte, ID; Francischi, JN; Tatsuo, MA; Veiga, AP | 1 |
| Nishiyama, T | 1 |
| Lee, IO; Seo, Y | 1 |
| Déciga-Campos, M; Granados-Soto, V; Medina-Santillan, R; Reyes-García, G | 1 |
| Abd El Razik, HA; Bekhit, AA; Bistawroos, AA; El-Mallah, A; Mohy El-Din, MM; Nour El-Din, NA; Senbel, AM | 1 |
| Dong, YL; Gu, ZX; Lu, GJ; Sun, YH; Wang, W; Wang, YT; Wu, SX; Yang, J; Zhao, GL | 1 |
| Guo, XJ; Liang, JC; Sun, Y; Tang, K; Wang, HY; Wang, Y; Wang, YT; Yin, JB; Zhao, YQ | 1 |
| Al-Wabli, R; El-Haggar, R; Fouad, M | 1 |
| Izadi, G; Sepehri, G; Shamsi Meymandi, M; Zamiri, Z | 1 |
| Azouz, AA; Bakr, RB; Ghoneim, AA | 1 |
| Abdel-Bary, A; El-Tahan, RA; Gowayed, MA | 1 |
| Abdelhady, SA; Abdelmawgoud, EM; Al-Shafie, TA; Ali, MA; El-Mas, MM; Yacout, DM | 1 |
| Lukіаnova, LV; Savelieva, OV; Syrova, GO; Tishakova, TS | 1 |
20 other study(ies) available for celecoxib and formaldehyde
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord.
Topics: Animals; Behavior, Animal; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Formaldehyde; Isoenzymes; Membrane Proteins; Microdialysis; Pain; Pain Measurement; Posterior Horn Cells; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spinal Cord; Sulfonamides | 2001 |
Participation of COX, IL-1 beta and TNF alpha in formalin-induced inflammatory pain.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Blocking; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Female; Formaldehyde; Inflammation; Interleukin-1; Male; Pain; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Tumor Necrosis Factor-alpha | 2001 |
The role of cyclooxygenase-1 and -2 in the rat formalin test.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Formaldehyde; Indomethacin; Injections, Spinal; Isoenzymes; Male; Membrane Proteins; Neural Conduction; Pain; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2002 |
Comparison of the antinociceptive effect of celecoxib, diclofenac and resveratrol in the formalin test.
Topics: Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Female; Formaldehyde; Inflammation; Pain; Pyrazoles; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sulfonamides | 2002 |
Modulation of inflammatory paw oedema by cysteamine in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Celecoxib; Corticotropin-Releasing Hormone; Cystamine; Edema; Formaldehyde; Histamine; Indomethacin; Pyrazoles; Rats; Somatostatin; Substance P; Sulfonamides; Tumor Necrosis Factor-alpha | 2002 |
Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats.
Topics: Animals; Arachidonic Acids; Atenolol; Behavior, Animal; Biogenic Amines; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Captopril; Celecoxib; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Facial Pain; Formaldehyde; Guanethidine; Hindlimb; Indomethacin; Injections, Subcutaneous; Interleukin-6; Interleukin-8; Lip; Male; Meloxicam; Nociceptors; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Sulfonamides; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha; Tyramine | 2004 |
Prevention by celecoxib of secondary hyperalgesia induced by formalin in rats.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Disease Models, Animal; Formaldehyde; Hyperalgesia; Injections, Spinal; Injections, Subcutaneous; Male; Piroxicam; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Tail | 2004 |
Analgesic effects of intrathecally administered celecoxib, a cyclooxygenase-2 inhibitor, in the tail flick test and the formalin test in rats.
Topics: Analgesia; Analysis of Variance; Animals; Behavior, Animal; Celecoxib; Cyclooxygenase 2 Inhibitors; Disinfectants; Dose-Response Relationship, Drug; Formaldehyde; Hemodynamics; Hot Temperature; Inflammation; Injections, Spinal; Male; Motor Activity; Pain; Physical Stimulation; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors | 2006 |
The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or nonselective inhibitors on pain behavior and spinal Fos-like immunoreactivity.
Topics: Animals; Behavior, Animal; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Formaldehyde; Hyperalgesia; Immunohistochemistry; Injections, Spinal; Ketorolac; Male; Membrane Proteins; Pain; Pain Measurement; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors | 2008 |
Comparison of antinociceptive efficacy and gastroprotection between celecoxib and diclofenac plus misoprostol in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Combinations; Female; Formaldehyde; Gastric Mucosa; Misoprostol; Pain Measurement; Pyrazoles; Rats; Rats, Wistar; Stomach Ulcer; Sulfonamides | 2007 |
A novel COX-2 inhibitor pyrazole derivative proven effective as an anti-inflammatory and analgesic drug.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Benzenesulfonamides; Carrageenan; Celecoxib; Chronic Disease; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Edema; Female; Formaldehyde; Hyperalgesia; Indomethacin; Inflammation; Male; Mice; Pyrazoles; Rats; Sulfonamides; Ulcer | 2011 |
Synergistic analgesia of duloxetine and celecoxib in the mouse formalin test: a combination analysis.
Topics: Analgesics; Analysis of Variance; Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Duloxetine Hydrochloride; Formaldehyde; Hindlimb; Injections, Intraperitoneal; Male; Mice, Inbred C57BL; Motor Activity; Nociceptive Pain; Pain Measurement; Pyrazoles; Sulfonamides; Thiophenes | 2013 |
The Analgesic Effects of Celecoxib on the Formalin-induced Short- and Long-term Inflammatory Pain.
Topics: Analgesics; Animals; Celecoxib; Dose-Response Relationship, Drug; Formaldehyde; Hyperalgesia; Male; Mice, Inbred C57BL; Pain; Pain Measurement | 2017 |
Synthesis, In-vivo and In-vitro Anti-inflammatory Evaluation of some Novel Coumarin Derivatives.
Topics: Albumins; Animals; Anti-Inflammatory Agents; Celecoxib; Coumarins; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Erythrocyte Membrane; Formaldehyde; Hemolysis; Male; Molecular Structure; Protein Denaturation; Rats; Structure-Activity Relationship | 2018 |
Evidence for antinociceptive effects of combined administration of vitamin E and celecoxib in tail-flick and formalin test in male rats.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Formaldehyde; Indomethacin; Male; Pain; Pain Measurement; Rats; Rats, Wistar; Vitamin E | 2019 |
Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Edema; Formaldehyde; Indomethacin; Male; Molecular Docking Simulation; Molecular Structure; Rats; Rats, Wistar; Sheep; Structure-Activity Relationship; Thiazoles; Ulcer | 2019 |
The effective interplay of (non-) selective NSAIDs with neostigmine in animal models of analgesia and inflammation.
Topics: Acetic Acid; Analgesia; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Diclofenac; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Edema; Female; Formaldehyde; Neostigmine; Pain; Rats, Sprague-Dawley | 2021 |
Montelukast potentiates the antiinflammatory effect of NSAIDs in the rat paw formalin model and simultaneously minimizes the risk of gastric damage.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclopropanes; Diclofenac; Formaldehyde; Inflammation; Male; Nitric Oxide Synthase Type II; Quinolines; Rats; Rats, Wistar; Risk; Signal Transduction; Stomach; Sulfides | 2021 |
EXPERIMENTAL RESEARCH OF THE EFFECT OF COXIBS ON THE CERULOPLASMIN LEVEL IN RAT SERUM ON THE FORMALIN-INDUCED EDEMA MODEL.
Topics: Animals; Anti-Inflammatory Agents; Benzenesulfonamides; Celecoxib; Ceruloplasmin; Cyclooxygenase 2 Inhibitors; Edema; Formaldehyde; Furans; Inflammation; Sodium | 2022 |